← Back to all announcements

Dr. Anne K. Ellis appointed James H. Day Chair in Allergic Diseases & Allergy Research

  • Published Wed Jul 15th 2015

    Dr. Anne K. Ellis appointed James H. Day Chair in Allergic Diseases and Allergy Research, Faculty of Health Sciences

    Provost and Vice-Principal (Academic) Alan Harrison is pleased to announce the appointment of Dr. Anne K. Ellis as the James H. Day Chair in Allergic Diseases and Allergy Research for the Faculty of Health Sciences. This appointment is for a five-year period from May 1, 2015 to April 30, 2020.

    After graduating in 1995 with her Bachelor of Science in Biomedical Sciences from the University of Guelph, Dr. Ellis came to Queen’s University to pursue her Doctor of Medicine, graduating from the School of Medicine in 1999. She completed her residency at Queen’s University in Internal Medicine in 2003, followed by a research fellowship in Queen’s Department of Medicine’s Division of Allergy and Immunology. In 2004, Dr. Ellis became a Fellow in Training with the Division of Allergy and Clinical Immunology at McMaster University, completing her training in 2006. Shortly afterwards, she completed her Master of Science at McMaster University, graduating in 2008.

    From 2006 to 2008, Dr. Ellis was appointed as a Clinical Scholar with McMaster University’s Division of Allergy and Clinical Immunology. She returned to Queen’s University in 2008 as an Assistant Professor in the Division of Allergy and Immunology within the Department of Medicine, with a cross-appointment to the Department of Biomedical and Molecular Sciences. She was promoted to Associate Professor in 2012. Her position is one of a Clinician Scientist with 75% protected time for research. 

    She has served as the Chair of the Division of Allergy & Immunology since May 2010, and is the Director of the Allergy Research Unit of Kingston General Hospital; the flagship of this research program being the Environmental Exposure Unit (EEU), an internationally recognized and validated controlled allergen challenge model of allergic rhinitis. She is also the Co-Director of the Allergic Rhinitis Clinical Investigator Collaborative (AR-CIC), a national multi-centre network of allergic rhinitis researchers, which receives federal funding via AllerGen NCE. 

    Dr. Ellis also runs a basic science research program centered on the Kingston Allergy Birth Cohort study, a prospective birth cohort that has enrolled over 400 pregnant women to date, in order to study umbilical cord blood biomarkers that could be predictive of future atopic disease in childhood. She has gained particular expertise in the evaluation of epigenetic modifications as they relate to atopic risk and also epigenetic changes that occur as a result of allergic inflammation.   

    At Queen’s, Dr. Ellis has overseen the studies and work of more than 60 students, residents, and other trainees. She served from September 2009 until June 2015 on the FHS Research Advisory Council, and currently sits on the FHS Industry Liasion Council. She has also served as the Chair of the Annual Resident Research Day for the Department of Medicine since 2011.

    Outside Queen’s University, Dr. Ellis is an Associate Editor of Annals of Allergy, and sits on the Board of Directors for both Clinical Trials Ontario, and the Canadian Society of Allergy and Clinical Immunology. She is also an Editoral Board member of Allergy, Asthma, and Clinical Immunology, and an Editor-at-Large for the World Allergy Organization Journal.

    Dr. Ellis is an active member of eight organizations, including the Ontario Medical Association, the Canadian Medical Association, and the Canadian Thoracic Society. She is also a Fellow of both the Royal College of Physicians and Surgeons, the American Academy of Allergy, Asthma, and Immunology, and the American College of Allergy, Asthma and Immunology. 

    Dr. Ellis has been invited to lecture over 70 times, and is a named author of more than 60 publications. She has also presented 100 abstracts at scientific conferences.